131 related articles for article (PubMed ID: 20629151)
21. Reproducibility and diagnostic accuracy of substantia nigra sonography for the diagnosis of Parkinson's disease.
van de Loo S; Walter U; Behnke S; Hagenah J; Lorenz M; Sitzer M; Hilker R; Berg D
J Neurol Neurosurg Psychiatry; 2010 Oct; 81(10):1087-92. PubMed ID: 20543186
[TBL] [Abstract][Full Text] [Related]
22. Substantia Nigra Echogenicity Associated with Clinical Subtypes of Parkinson's Disease.
Zhou HY; Huang P; Sun Q; Du JJ; Cui SS; Tan YY; Hu YY; Zhan WW; Wang Y; Xiao Q; Liu J; Chen SD
J Parkinsons Dis; 2018; 8(2):333-340. PubMed ID: 29614699
[TBL] [Abstract][Full Text] [Related]
23. Transcranial Sonographic Alterations of Substantia Nigra and Third Ventricle in Parkinson's Disease with or without Dementia.
Dong ZF; Wang CS; Zhang YC; Zhang Y; Sheng YJ; Hu H; Luo WF; Liu CF
Chin Med J (Engl); 2017 Oct; 130(19):2291-2295. PubMed ID: 28937033
[TBL] [Abstract][Full Text] [Related]
24. Combination of olfactory test and substantia nigra transcranial sonopraphy in the differential diagnosis of Parkinson's disease: a pilot study from China.
Chen W; Tan YY; Hu YY; Zhan WW; Wu L; Lou Y; Wang X; Zhou Y; Huang P; Gao Y; Xiao Q; Chen SD
Transl Neurodegener; 2012 Dec; 1(1):25. PubMed ID: 23267690
[TBL] [Abstract][Full Text] [Related]
25. Midbrain hyperechogenicity, hyposmia, mild parkinsonian signs and risk for incident Parkinson's disease over 10 years: A prospective population-based study.
Mahlknecht P; Stockner H; Marini K; Gasperi A; Djamshidian A; Willeit P; Kiechl S; Willeit J; Rungger G; Poewe W; Seppi K
Parkinsonism Relat Disord; 2020 Jan; 70():51-54. PubMed ID: 31864071
[TBL] [Abstract][Full Text] [Related]
26. Vulnerability of the nigrostriatal system as detected by transcranial ultrasound.
Berg D; Becker G; Zeiler B; Tucha O; Hofmann E; Preier M; Benz P; Jost W; Reiners K; Lange KW
Neurology; 1999 Sep; 53(5):1026-31. PubMed ID: 10496262
[TBL] [Abstract][Full Text] [Related]
27. Midbrain sonography in patients with essential tremor.
Stockner H; Sojer M; K KS; Mueller J; Wenning GK; Schmidauer C; Poewe W
Mov Disord; 2007 Feb; 22(3):414-7. PubMed ID: 17226854
[TBL] [Abstract][Full Text] [Related]
28. Transcranial imaging of substantia nigra hyperechogenicity in a Taiwanese cohort of Parkinson's disease.
Huang YW; Jeng JS; Tsai CF; Chen LL; Wu RM
Mov Disord; 2007 Mar; 22(4):550-5. PubMed ID: 17260344
[TBL] [Abstract][Full Text] [Related]
29. Long-term course of substantia nigra hyperechogenicity in Parkinson's disease.
Behnke S; Runkel A; Kassar HA; Ortmann M; Guidez D; Dillmann U; Fassbender K; Spiegel J
Mov Disord; 2013 Apr; 28(4):455-9. PubMed ID: 23115064
[TBL] [Abstract][Full Text] [Related]
30. Relevance of substantia nigra hyperechogenicity and reduced odor identification in idiopathic REM sleep behavior disorder.
Iwanami M; Miyamoto T; Miyamoto M; Hirata K; Takada E
Sleep Med; 2010 Apr; 11(4):361-5. PubMed ID: 20223708
[TBL] [Abstract][Full Text] [Related]
31. Lateralized microstructural changes in early-stage Parkinson's disease in anterior olfactory structures, but not in substantia nigra.
Joshi N; Rolheiser TM; Fisk JD; McKelvey JR; Schoffer K; Phillips G; Armstrong M; Khan MN; Leslie RA; Rusak B; Robertson HA; Good KP
J Neurol; 2017 Jul; 264(7):1497-1505. PubMed ID: 28653210
[TBL] [Abstract][Full Text] [Related]
32. Substantia nigra hyperechogenicity correlates with subtle motor dysfunction in tap dancers.
Ruprecht-Dörfler P; Klotz P; Becker G; Berg D
Parkinsonism Relat Disord; 2007 Aug; 13(6):362-4. PubMed ID: 17055330
[TBL] [Abstract][Full Text] [Related]
33. Combination of transcranial sonography, olfactory testing, and MIBG myocardial scintigraphy as a diagnostic indicator for Parkinson's disease.
Izawa MO; Miwa H; Kajimoto Y; Kondo T
Eur J Neurol; 2012 Mar; 19(3):411-6. PubMed ID: 21978091
[TBL] [Abstract][Full Text] [Related]
34. Association Between Asymmetry of Substantia Nigra Hyperechogenicity and Clinical Characteristics in Different Parkinson Disease Subtypes: A 5-Year Follow-up Study.
Fu XY; Zhang YC; Ding CW; Zhao P; Liu QY; Yang M; Wang CS; Chen XF; Zhang Y; Sheng YJ; Mao P; Mao CJ; Liu CF
Ultrasound Med Biol; 2022 Oct; 48(10):2139-2145. PubMed ID: 35953347
[TBL] [Abstract][Full Text] [Related]
35. Transcranial brain sonography in Parkinson's disease with restless legs syndrome.
Kwon DY; Seo WK; Yoon HK; Park MH; Koh SB; Park KW
Mov Disord; 2010 Jul; 25(10):1373-8. PubMed ID: 20544813
[TBL] [Abstract][Full Text] [Related]
36. Transcranial sonography (TCS) in Parkinson's disease (PD) and essential tremor (ET) in relation with putative premotor symptoms of PD.
Kim JS; Oh YS; Kim YI; Koo JS; Yang DW; Lee KS
Arch Gerontol Geriatr; 2012; 54(3):e436-9. PubMed ID: 22277379
[TBL] [Abstract][Full Text] [Related]
37. Substantia nigra echomorphology in the healthy very old: Correlation with motor slowing.
Behnke S; Double KL; Duma S; Broe GA; Guenther V; Becker G; Halliday GM
Neuroimage; 2007 Feb; 34(3):1054-9. PubMed ID: 17141529
[TBL] [Abstract][Full Text] [Related]
38. Life-long increase of substantia nigra hyperechogenicity in transcranial sonography.
Hagenah J; König IR; Sperner J; Wessel L; Seidel G; Condefer K; Saunders-Pullman R; Klein C; Brüggemann N
Neuroimage; 2010 May; 51(1):28-32. PubMed ID: 20152909
[TBL] [Abstract][Full Text] [Related]
39. Feature analysis for Parkinson's disease detection based on transcranial sonography image.
Chen L; Hagenah J; Mertins A
Med Image Comput Comput Assist Interv; 2012; 15(Pt 3):272-9. PubMed ID: 23286140
[TBL] [Abstract][Full Text] [Related]
40. Asymmetrical diffusion tensor imaging indices of the rostral substantia nigra in Parkinson's disease.
Prakash BD; Sitoh YY; Tan LC; Au WL
Parkinsonism Relat Disord; 2012 Nov; 18(9):1029-33. PubMed ID: 22705126
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
